CDKN2A and head and neck squamous cell carcinoma: Based on our knowledge (PubMed, Medline databases), this has been the first study to analyze the concentrations of CDKN2A and Ki-67 proteins in tumor and surgical margin homogenates obtained from patients with HNSCC by immunoassay (ELISA).